Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • Aug. 07, 2026, 12:56 UTC
  • 0
  • 1 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • Aug. 07, 2026, 12:56 UTC
  • 0
  • 1 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

COURSERA, INC. (COUR)

  • Business News
  • Aug. 07, 2026, 12:56 UTC
  • 0
  • 1 comments

COURTOIS SA : Variation droits de vote 07/2026

Market reaction Comment Full text

LOMA NEGRA COMPANIA INDUSTRIAL ARGENTINA SOCIEDAD ANONIMA (LOMA)

  • Business News
  • Aug. 07, 2026, 12:55 UTC
  • 0
  • 1 comments

NYSE Content Update: Pinnacle Acquisition + Ticketplus to Debut for Trade

Market reaction Comment Full text

LIVEPERSON INC. (LPSN)

  • Business News
  • Aug. 07, 2026, 12:54 UTC
  • 0
  • 1 comments

Other Report or Announcement

Market reaction Comment Full text

LIVEPERSON INC. (LPSN)

  • Business News
  • Aug. 07, 2026, 12:53 UTC
  • 0
  • 1 comments

Other Report or Announcement

Market reaction Comment Full text

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED (T14)

  • Business News
  • Aug. 07, 2026, 12:45 UTC
  • 0
  • 1 comments

General Announcement: THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION

Market reaction Comment Full text

ATOSSA THERAPEUTICS, INC. (ATOS)

  • Business News
  • Aug. 07, 2026, 12:45 UTC
  • 0
  • 1 comments

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Market reaction Comment Full text

ABBVIE INC. (ABBV)

  • Business News
  • Aug. 07, 2026, 12:44 UTC
  • 0
  • 1 comments

Clinical trial NCT07291232 updates: 1. completion date: 2026-10-01 → 2027-03-01 2. primary completion date: 2026-10-01 → 2027-03-01 3. enrollment: 48 → 80 participants

Market reaction Comment Full text

NOVARTIS AG (NVSEF)

  • Business News
  • Aug. 07, 2026, 12:44 UTC
  • 0
  • 1 comments

Clinical trial NCT04689828: completion date: 2026-09-30 → 2026-09-10.

Market reaction Comment Full text
  • Previous
  • 435
  • 436
  • 437
  • 438
  • 439
  • Next

Search

News categories

  • Technical Exchange News(14262)
  • Event(6229)
  • SEC News(368098)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(226349)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin